Biosurgical Agents | Market Insights | Japan | 2021
Although it will be impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Japan will grow at a moderate rate through 2029, driven by rising surgical procedure volumes, the introduction of new products, and expanding indications for the existing products.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Biosurgical Agents in Japan across a 10-year period.